The Complement-Glycocalyx Axis in Myocardial Ischemia-Reperfusion Injury: A Proposed Endothelial Checkpoint Linking Inflammation to Microvascular Obstruction
- 14 November 2026
- journal article
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 8 (1)
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Activation of the C3a–C3aReceptor-axis is associated with endothelial dysfunction and glycocalyx damage in ST-elevation myocardial infarctionBasic Research in Cardiology, 2026
- Endothelial Glycocalyx and Cardiomyocyte Damage Is Prevented by Recombinant Syndecan-1 in Acute Myocardial InfarctionThe American Journal of Pathology, 2023
- The Glycocalyx and Its Role in Vascular Physiology and Vascular Related DiseasesCardiovascular Engineering and Technology, 2020
- Endothelial Glycocalyx Impairment in DiseaseThe American Journal of Pathology, 2020
- Glycocalyx Degradation in Ischemia-Reperfusion InjuryThe American Journal of Pathology, 2020
- Coronary microvascular obstruction: the new frontier in cardioprotectionBasic Research in Cardiology, 2019
- Endothelial glycocalyx and coronary vascular permeability: the fringe benefitBasic Research in Cardiology, 2010
- TNF-α induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombinBasic Research in Cardiology, 2008
- Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary InterventionJAMA, 2007
- The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusionBasic Research in Cardiology, 2006